Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-08-22
1997-10-21
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 15, 530326, 530328, A61K 3800, C07K 706, C07K 708
Patent
active
056796390
ABSTRACT:
The present invention describes polypeptides and anti-peptide antibodies capable of inhibiting serine protease enzymatic activity. In particular, polypeptides and anti-peptide antibodies derived from the blood coagulation serine proteases Factor VIIa, Factor IXa, Factor Xa, Factor XIa, thrombin and plasma kallikrein are described that are capable of inhibiting coagulation. The polypeptide and antibody are useful in methods and systems for inhibiting serine proteases, and particularly for inhibiting blood coagulation processes mediated by serine proteases in vitro or in a human patient.
REFERENCES:
Kumar et al, J. Biol. Chem, vol. 266, No. 2, 15 Jan. 1991, pp. 915-921.
Haley, et al., J. Biol. Chem, vol. 264, No. 27, 25 Sep.
James et al, Blood, vol. 77, No. 2 , (Jan. 15), 1991: pp. 317-323.
Esmon, et al, Proc. Natl. Acad. Sci, USA, vol. 78, No. 4, pp. 2249-2252, 1981.
Beckmann, et al., Nucleic Acids Res., 13: 5233-5247 (1985).
Brown, et al., Biochem. J., 101: 214-228 (1966).
Choo, et al., Nature, 299:178-180 (1982).
Degen, et al., Biochemistry, 22: 2087-2097 (1983).
Esmon, et al., Ann. N.Y. Acad. Sci., 614: 30-43 (1991).
Foster, et al., Proc. Natl. Acad. Sci. USA, 82: 4673-4677 (1985).
Gruber, et al., Blood, 73: 639-642 (1989).
Hagen, et al., Proc. Natl. Acad. Sci. USA, 83: 2412-2416 (1986).
Haley, et al., J. Biol. Chem., 264: 16303-16310 (1989).
Heeb, et al., J. Biol. Chem., 265: 2365-2369 (1990).
James, et al., Blood, 77: 317-323 (1991).
Kisiel, et al., J. Clin. Invest., 64: 761-769 (1979).
Krishnaswamy, et al., J. Biol. Chem., 261: 9684-9693 (1986).
Kumar, et al., J. Biol. Chem., 266: 915-921 (1991).
Leytus, et al., Proc. Natl. Acad. Sci. USA, 81: 3699-3702 (1984).
Marear, et al., Blood, 59: 1067-1072 (1982).
Mikes, et al, Biochem. Biophys. Res. Comm., 24: 346-352 (1966).
Ohlin, et al., Biochem, 29: 644-651 (1990).
Plutzsky, et al., Proc. Natl. Acad. Sci USA, 83: 546-550 (1986).
Sadowski, et al., J. Biol. Chem., 251: 2770-2776 (1976).
Seegers, et al., Thrombosis Res., 13: 233-243 (1978).
Solymoss, et al., J. Biol. Chem., 263: 14884-14890 (1988).
Sugo, et al., J. Biol. Chem., 260: 10453-10457 (1985).
Suzuki, et al., J. Biol. Chem., 258: 163-168 (1983).
Walker, et al., J. Biol. Chem., 265: 1484-1489 (1990).
Griffin John H.
Mesters Rolf M.
Fitting Thomas
Holmes Emily
Marshall S. G.
The Scripps Research Institute
Tsang Cecilia J.
LandOfFree
Serine protease derived-polypeptides and anti-peptide antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Serine protease derived-polypeptides and anti-peptide antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Serine protease derived-polypeptides and anti-peptide antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1006709